Gilead Sciences (GILD) Other Non-Current Liabilities (2009 - 2026)

Gilead Sciences (GILD) has 18 years of Other Non-Current Liabilities data on file, last reported at $1.2 billion in Q1 2026.

• For the quarter ending Q1 2026, Other Non-Current Liabilities fell 10.25% year-over-year to $1.2 billion; the trailing twelve-month figure through Mar 2026 stood at $1.2 billion (down 10.25% YoY), and the FY2025 full-year result was $896.0 million, up 7.95% from the prior year.
• Other Non-Current Liabilities for Q1 2026 stood at $1.2 billion, up from $896.0 million in the prior quarter.
• Across five years, Other Non-Current Liabilities topped out at $3.8 billion in Q1 2023 and bottomed at $830.0 million in Q4 2024.
• The 5-year median for Other Non-Current Liabilities is $1.2 billion (2026), against an average of $1.4 billion.
• The widest annual swing landed in 2023, when Other Non-Current Liabilities soared 299.89%; it then slumped 63.05% in 2024.
• A 5-year view of Other Non-Current Liabilities shows it stood at $1.2 billion in 2022, then grew by 8.57% to $1.3 billion in 2023, then tumbled by 35.16% to $830.0 million in 2024, then increased by 7.95% to $896.0 million in 2025, then jumped by 33.93% to $1.2 billion in 2026.
• The last three Other Non-Current Liabilities figures came in at $1.2 billion (Q1 2026), $896.0 million (Q4 2025), and $1.2 billion (Q3 2025), per Business Quant data.

Peer Comparison